ONCOTHERAPY SCIENCE, INC. Funds and ETFs OncoTherapy Science, Inc.
Equities
4564
JP3202150003
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17 JPY | 0.00% |
|
-10.53% | -26.09% |
OncoTherapy Science, Inc. is a Japan-based company mainly engaged in the development of drugs. The Company is involved in the development of low molecular drugs, antibody drugs and other drugs, as well as the provision and clinical development of medical candidate substances. The Company operates its business in cooperation with universities and other corporations. The Company provides its licenses to pharmaceutical manufacturers. The Company also involves in T Cell Receptor(TCR) analysis business.
Calendar
2024-08-01
- Q1 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -26.09% | 23.5M | |
| -2.31% | 103B | |
| +0.56% | 95.28B | |
| +0.47% | 22.15B | |
| -17.37% | 21.02B | |
| -8.96% | 18.15B | |
| -41.01% | 16.73B | |
| -14.85% | 16.05B | |
| +3.21% | 13.68B | |
| +33.54% | 12.17B |
- Stock Market
- Equities
- 4564 Stock
- Funds and ETFs OncoTherapy Science, Inc.
